Alternatively, a primary H-bonding interaction may be
preferred as in transition state B, with a secondary require-
ment for Li complexation to the Boc oxygen. Such an
arrangement would also be consistent with the observed
products, and both transition states call upon involvement
of the lithium counterion as demanded by the results from
the 12-crown-4 experiment.
against oxidation of amino sulfanes.23a,c,26 The key difference
is that the stereocenter influences oxygen delivery in the
oxidation protocol, whereas, in this chemistry, the chirality
influences carbonꢀsulfur bond formation of an already
monoxidized sulfur. Although the diastereoselective oxida-
tion of enantiopure amino sulfides has been utilized exten-
sively as a general method for amino sulfoxide formation, the
existing protocols do not deliver dr’s as consistently high as
reported herein. The potential preference of sulfenate chem-
istry for this purpose is particularly realized when compared
to an example where two chiral influences are required to
deliver dr’s as high as 93.5:6.5 in 59% yield.26d
To summarize, it has been shown that aromatic sulfe-
nateanionscan be alkylatedby chiralβ-aminoiodideswith
high diastereoselectivity. Moreover, the reaction is stereo-
specific when considered from the perspective of the elec-
trophilic (R)- and (S)-iodides. The alkylation chemistry
demonstrates a conceptually novel mode for the creation
of sulfur stereogenicity. Based on the examples shown, the
S-functionalization of the prochiral sulfenates holds the
potential to be superior to sulfur oxidation for the prepara-
tion of β-amino sulfoxides. An internal complexation of the
lithium counterion with the electrophile’s nitrogen is pro-
posed to play a key role in the stereoselection.
To address the question as to whether H-bonding is
involved or not, the N-methylated analog of 3 was selected
as an electrophile that would permit alkylation without
opportunity for H-bonding. However, attempts to convert
Boc-protected (S)-2-(methylamino)-3-phenylpropyl alco-
hol to its iodide led to decomposition of the Boc unit and
oxazoline formation. As an alternative that maintains
some structural similarities, L-prolinol was converted to
its corresponding iodide (15). The reaction of 1-Li with 15
provided 61% of amino sulfoxide 16, with a dr of 95:5
(Scheme 2). A single crystal X-ray structure analysis con-
firmed the configuration of the major isomer to be (RS,
SC),22 consistent with the stereochemistry of other alkyla-
tions with SC-amino iodides. The high diastereoselectivity
indicates that H-bonding is not a significant requirement
for diastereoselection and that complexing to the heteroa-
tom lone pair should be adequate to direct the stereochem-
istry in this and the other examples.
It should also be noted that a new family of sulfenate
electrophiles has been uncovered; the electrophile exhi-
bits increased reactivity based on the nature of remote
substitution, rather than on the degree of substitution
or identity of the leaving group at the electrophilic
carbon. We are exploring the substitution chemistry of
a larger set of electrophiles and sulfenates to establish
the scope of the chemistry and other influences on the
stereoselectivity.
Scheme 2. Alkylation of Lithium p-toluenesulfenate (1-Li) with
L-Prolinyl Iodide (15)
Acknowledgment. The authors thank Dr. J. S. O’Don-
nell and Ms. S. Joyce (nee Britton) (Univ. of Guelph) for
helpful experiments and Dr. Alan Lough (Univ. of
Toronto) for the crystallographic work. Acknowledgment
is also made to the Donors of the American Chemical
Society Petroleum Research Fund and to the Natural
Sciences and Engineering Research Council of Canada
for partial support of this research. S.C.S. also thanks
NSERC for a postgraduate scholarship.
Chiral β-amino sulfoxides have found utility as chiral
ligands,23 as effective organocatalysts24 and in the synthesis
of biologically or medicinally important compounds.25
Although various methods are available for their synthesis,20b
the sulfenate chemistry presented herein should be evaluated
(22) There is 7% disorder in the crystal due to the presence of the
minor isomer in the recrystallized sample (post HPLC analysis). See
Supporting Information. The crystal structure has been deposited at the
CCDC (# CCDC 827867).
Supporting Information Available. Experimental pro-
cedures and characterization data for products; X-ray
crystal structure data including .cif file. This material is
org.
(23) (a) Petra, D. G. I.; Kamer, P. C. J.; Spek, A. L.; Schoemaker,
H. E.; Van Leeuwen, P. W. N. M. J. Org. Chem. 2000, 65, 3010. (b)
Wojaczynska, E.; Zielinska-Blajet, M.; Turowska-Tyrk, I.; Skarzewski,
J. Tetrahedron: Asymmetry 2010, 21, 853. (c) Ekegren, J. K.; Roth, P.;
Kallstrom, K.; Tarnai, T.; Andersson, P. G. Org. Biomol. Chem. 2003, 1,
358. (d) Pettinari, C.; Pellei, M.; Cavicchio, G.; Crucianelli, M.; Panzeri,
W.; Colapietro, M.; Cassetta, A. Organometallics 1999, 18, 555. (e)
Hiroi, K.; Sone, T. Curr. Org. Synth. 2008, 5, 305. (f) Wojaczynska, E.;
Zielinska-Blajet, M.; Turowska-Tyrk, I.; Skarzewski, J. Tetrahedron:
Asymmetry 2010, 21, 853. (g) Corbi, P. P.; Massabni, A. C.; Sabeh,
L. P. B.; Costa-Neto, C. M. J. Coord. Chem. 2008, 61, 2470.
(24) (a) Mellah, M.; Voituriez, A.; Schulz, E. Chem. Rev. 2007, 107,
5133. (b) De, S. V.; Acocella, M. R.; Villano, R.; Scettri, A. Tetrahedron:
Asymmetry 2010, 21, 1432.
(26) (a) Brunet, E.; Gallego, M. T.; Garcia, R. J. L.; Parellada, D.;
Rodriguez, J. H.; Urbano, A. Tetrahedron 1988, 44, 1421. (b) Dureault,
A.; Carreaux, F.; Depezay, J. C. Synthesis 1991, 150. (c) Nakajima, N.;
Enomoto, T.; Matsuura, N.; Ubukata, M. Bioorg. Med. Chem. Lett.
1998, 8, 3331. (d) Nakajima, N.; Enomoto, T.; Watanabe, T.; Matsuura,
N.; Ubukata, M. Biosci., Biotechnol., Biochem. 2003, 67, 2556. (e)
Raghavan, S.; Rajender, A. Tetrahedron 2004, 60, 5059. (f) Siedlecka,
R.; Skarzewski, J. Synlett 1996, 757. (g) Quinet, C.; Sampoux, L.;
Marko, I. E. Eur. J. Org. Chem. 2009, 1806. (h) Meese, C. O. Arch.
Pharm. (Weinheim, Ger.) 1987, 320, 473. (i) Van, d. B. L. A. G. M.;
Lazaro, E.; Zylicz, Z.; Fennis, P. J.; Missler, F. A. N.; Lelieveld, P.;
Garzotto, M.; Wagener, D. J. T.; Ballesta, J. P. G.; Ottenheijm, H. C. J.
J. Med. Chem. 1989, 32, 2002.
(25) (a) Raghavan, S.; Krishnaiah, V.; Sridhar, B. J. Org. Chem.
2010, 75, 498. (b) Ma, D.; Zou, B.; Zhu, W.; Xu, H. Tetrahedron Lett.
2002, 43, 8511. (c) Huang, X.; Chen, D.; Wu, N.; Zhang, A.; Jia, Z.; Li,
X. Bioorg. Med. Chem. Lett. 2009, 19, 4130. (d) Raghavan, S.;
Krishnaiah, V. J. Org. Chem. 2010, 75, 748.
Org. Lett., Vol. 13, No. 16, 2011
4195